Clinical Trial Update: Phase II/III of Recombinant Human Albumin Injection [Phase 2]

View source ↗

Summary

A Phase II/III trial evaluating recombinant human albumin injection for hepatic ascites has completed its Phase 2 portion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Ascites

Drugs mentioned

• Recombinant Human Albumin Injection (recombinant human albumin)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Hepatic Ascites | Phase 2 | Status: COMPLETED